Agitation Clinical Trial
ED50 of dexmedetomidine for prevention of emergence agitation after tonsillectomy or adenoidectomy in children
n/a
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02525991 -
Phase IV to Evaluate the Safety of Self-administered ADASUVE® in Agitated Patients Outside the Hospital Setting
|
Phase 4 | |
Recruiting |
NCT05557409 -
A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation
|
Phase 3 | |
Completed |
NCT01976754 -
Safety Study of Dexmedetomidine in Septic Patients
|
N/A | |
Completed |
NCT01217541 -
Collaboration Between Department of Old Age Psychiatry and Nursing Homes
|
N/A | |
Withdrawn |
NCT00786318 -
Ziprasidone vs Standard Therapy for Agitated Patients in the ED
|
Phase 4 | |
Not yet recruiting |
NCT05974527 -
Pilot Study 1: Efficacy and Safety of Sublingual Dexmedetomidine (BXCL501) for the Treatment of Agitation in the Emergency Department
|
Phase 4 | |
Not yet recruiting |
NCT05522647 -
Detection of Risk Behaviors: Pilot Observational Study With Bedridden and Agitated Patients.
|
||
Recruiting |
NCT02590744 -
Effects of Preoperative Using of Eye Patches on Prevention of Emergence Agitation After Cataract Surgery
|
N/A | |
Recruiting |
NCT02164773 -
Addition of Magnesium Sulfate to Caudal to Prevent Postoperative Emergence Agitation.
|
Phase 4 | |
Completed |
NCT01524367 -
Effect of Single-dose Dexmedetomidine on Emergence Excitement in Adults With Nasotracheal Intubation After Orthognathic Surgery
|
Phase 4 | |
Completed |
NCT01501123 -
Pre-hospital Agitation and Sedation Trial: A Randomized Controlled Trial of Haloperidol Versus Midazolam for the Sedation of the Agitated Patient
|
N/A | |
Completed |
NCT01021696 -
Pain in Patients With Dementia and Behavioural Disturbances
|
Phase 2/Phase 3 | |
Recruiting |
NCT05397639 -
Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type
|
Phase 3 | |
Terminated |
NCT03044249 -
A Study of MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression
|
Phase 2 | |
Completed |
NCT05165914 -
Midazolam Effect on Agitation Postnasal Surgery
|
N/A | |
Completed |
NCT04010305 -
Sub-Lingual Dexmedetomidine in Agitation Associated With Schizophrenia
|
Phase 1 | |
Completed |
NCT02720705 -
Transbucal Dexmedetomidine for Prevention of Sevoflurane Emergence Agitation in Pre-school Children
|
Phase 2/Phase 3 | |
Completed |
NCT02428283 -
Scalp Nerve Block on Emergence Agitation
|
Phase 4 | |
Completed |
NCT00457366 -
A Comparison Study of the Efficacy of Quetiapine and Haloperidol in Agitated Adults in Emergency Room
|
Phase 4 | |
Terminated |
NCT00315900 -
Depakote Extended Release (ER) Versus Seroquel for Agitated Behaviors in Nursing Home Care Unit Patients With Dementia
|
Phase 3 |